Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making.

Expert review of gastroenterology & hepatology（2023）

引用 3|浏览11

暂无评分

摘要

Patients with NAFLD may be benefited by a better understanding of the disease biology, which involves 'dissection' of the molecular sub-phenotypes that drive the disease progression.

查看译文

关键词

NAFLD,NASH,OMICS,arterial hypertension,dyslipidemia,genetics,heterogeneity,metabolic syndrome,obesity,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要